Previous close | 0.7300 |
Open | 0.7400 |
Bid | 0.7500 x 0 |
Ask | 0.7700 x 0 |
Day's range | 0.7300 - 0.7700 |
52-week range | 0.4600 - 6.4400 |
Volume | |
Avg. volume | 10,023,804 |
Market cap | 638.395M |
Beta (5Y monthly) | 2.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.1100 |
Earnings date | 07 Feb 2024 - 12 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.81 |
Sleep deprived? Stressed? Sore? Martha Stewart has a CBD gummy for that!
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today provided an update that pursuant to the proceedings under the Companies' Creditors Arrangement Act (the "CCAA") involving BioSteel Sports Nutrition Inc. ("BioSteel Canada"), the Ontario Superior Court of Justice (Commercial List) ("CCAA Court") has approved two transactions to sell all or substantially all of the assets of BioSteel Canada and BioSteel Manufacturing, LLC ("BioSteel Manufacturing") and tha
Key Takeaways; Cannabis Sector • Organigram received C$124.6 million investment from BAT; the company also announced the appointment of an interim CFO. • Trulieve posts robust Q3 2023 financial results, showcasing strong financial performance, debt reduction, and strategic growth initiatives. • Canopy Growth reported narrowed Q2 losses, indicating a positive shift amid restructuring efforts. • […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclus